OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded Contract SPE2DP26F6341 to DMS PHARMACEUTICAL GROUP INC under the existing delivery order SPE2DX25D9900, with an award date of June 4, 2026. The contract is for the supply of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068, and the total contract value is specified in the award documentation. The procurement is part of a federal acquisition effort managed by the Department of Defense, with no set-aside designation applied. Performance obligations are tied to the federal supply system, and the place of performance is not explicitly defined beyond the country code United States. The contract was posted on the DIBBS portal on July 21, 2026, and the official record can be accessed through the provided DIBBS link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
